BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27629421)

  • 1. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.
    Geeroms B; Laleman W; Laenen A; Heye S; Verslype C; van der Merwe S; Nevens F; Maleux G
    Eur Radiol; 2017 May; 27(5):1795-1803. PubMed ID: 27629421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.
    Maleux G; Nevens F; Wilmer A; Heye S; Verslype C; Thijs M; Wilms G
    Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA; Karnel F; Georgieva B; Tauss J; Portugaller H; Deutschmann H; Berghold A
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
    Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.
    Bureau C; Garcia Pagan JC; Layrargues GP; Metivier S; Bellot P; Perreault P; Otal P; Abraldes JG; Peron JM; Rousseau H; Bosch J; Vinel JP
    Liver Int; 2007 Aug; 27(6):742-7. PubMed ID: 17617116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary implantation of polyester-covered stent-grafts for transjugular intrahepatic portosystemic stent shunts (TIPSS): A pilot study.
    Cejna M; Thurnher S; Pidlich J; Kaserer K; Schoder M; Lammer J
    Cardiovasc Intervent Radiol; 1999; 22(4):305-10. PubMed ID: 10415220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
    Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts.
    Kochar N; Tripathi D; McAvoy NC; Ireland H; Redhead DN; Hayes PC
    Aliment Pharmacol Ther; 2008 Aug; 28(3):294-303. PubMed ID: 19086235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study.
    Maleux G; Perez-Gutierrez NA; Evrard S; Mroue A; Le Moine O; Laleman W; Nevens F
    Acta Gastroenterol Belg; 2010; 73(3):336-41. PubMed ID: 21086935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.
    Tripathi D; Ferguson J; Barkell H; Macbeth K; Ireland H; Redhead DN; Hayes PC
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):225-32. PubMed ID: 16462534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
    Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
    Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.
    Luo X; Zhao M; Wang X; Jiang M; Yu J; Li X; Yang L
    PLoS One; 2019; 14(2):e0212658. PubMed ID: 30811467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
    Charon JP; Alaeddin FH; Pimpalwar SA; Fay DM; Olliff SP; Jackson RW; Edwards RD; Robertson IR; Rose JD; Moss JG
    J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts.
    Weber CN; Nadolski GJ; White SB; Clark TW; Mondschein JI; Stavropoulos SW; Shlansky-Goldberg RD; Trerotola SO; Soulen MC
    J Vasc Interv Radiol; 2015 Sep; 26(9):1257-65; quiz 1265. PubMed ID: 25990133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
    World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of transjugular intrahepatic portosystemic shunt with PTFE-covered stents after liver transplantation and technical results in split and whole liver graft recipients.
    Maruzzelli L; D'Amico M; Tuzzolino F; Petridis I; Gruttadauria S; Miraglia R; Luca A
    Eur Radiol; 2023 Apr; 33(4):2612-2619. PubMed ID: 36418620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.
    Bettinger D; Knüppel E; Euringer W; Spangenberg HC; Rössle M; Thimme R; Schultheiß M
    Aliment Pharmacol Ther; 2015 Jan; 41(1):126-36. PubMed ID: 25329493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.